Investment
Features
FeesSafety
Academy
More
Pluang+

IQSTEL targets $430M revenue in 2026, launching high-margin AI, cybersecurity, fintech, and digital health services.

Company Fundamentals
26 May 2026
PRNewsWire
View Source
Bullish
pluang ai news

IQSTEL Inc. reported strong Q1 2026 results with $97.9 million revenue, up 69.9% year-over-year, and reaffirmed its $430 million revenue target for 2026. The company is shifting from telecom operations to a digital services platform, launching high-margin AI, cybersecurity, fintech, and digital health services globally. These new services are expected to boost profitability with margins up to 40% for AI and over 25% for cybersecurity. IQSTEL's global telecom relationships and recent acquisitions support its growth and transformation strategy, aiming to become a $1 billion annual revenue company in the long term.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Klarna's growth driven by strong financing, low-cost funding, and expanding customer base despite market volatility risks.

Klarna's growth driven by strong financing, low-cost funding, and expanding customer base despite market volatility risks.

Klarna benefits from maturing financing cohorts, low-cost deposit funding, and prudent risk management, leading to increased transaction margins and net interest income. This supports their growth strategy, reflected in accelerating gross merchandise...

Analyst Insights
Bullish
4 hours ago
Vishay earns CMMC Level 2 certification to secure U.S. defense program data handling.

Vishay earns CMMC Level 2 certification to secure U.S. defense program data handling.

Vishay Intertechnology has achieved Level 2 Cybersecurity Maturity Model Certification (CMMC), confirming its cybersecurity meets U.S. Department of Defense standards for handling sensitive defense information. This certification allows Vishay to sec...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App